{"id":4490,"date":"2025-09-16T12:21:35","date_gmt":"2025-09-16T09:21:35","guid":{"rendered":"https:\/\/dmdwarrior.com\/?p=4490"},"modified":"2025-09-16T12:31:54","modified_gmt":"2025-09-16T09:31:54","slug":"givinostat-duvyzat-distribution-brazil","status":"publish","type":"post","link":"https:\/\/dmdwarrior.com\/fr\/givinostat-duvyzat-distribution-brazil\/","title":{"rendered":"Italfarmaco et Multicare Pharma signent un accord de distribution exclusif pour Givinostat (Duvyzat), un traitement contre la DMD au Br\u00e9sil"},"content":{"rendered":"<p class=\"wp-block-paragraph\">Italfarmaco a annonc\u00e9 un accord exclusif avec Multicare Pharma, une importante soci\u00e9t\u00e9 pharmaceutique d&#039;Am\u00e9rique latine. <strong>Multicare Pharma soutiendra l&#039;approbation r\u00e9glementaire au Br\u00e9sil et distribuera le givinostat (Duvyzat), le nouvel inhibiteur de l&#039;histone d\u00e9sac\u00e9tylase (HDAC) d&#039;Italfarmaco pour traiter la dystrophie musculaire de Duchenne (DMD).<\/strong> Selon les termes de l&#039;accord, Multicare g\u00e9rera les op\u00e9rations d&#039;approvisionnement et de distribution du m\u00e9dicament au Br\u00e9sil. Les modalit\u00e9s financi\u00e8res n&#039;ont pas \u00e9t\u00e9 divulgu\u00e9es. \u2013 Lire\u00a0: <a href=\"https:\/\/dmdwarrior.com\/fr\/duvyzat-givinostat-nonsteroidal-drug\/\" data-type=\"post\" data-id=\"3957\">Qu&#039;est-ce que Duvyzat ?<\/a> \u2013<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u00ab Chez Italfarmaco, notre engagement envers les maladies rares guide chacune de nos d\u00e9cisions. L&#039;acc\u00e8s au givinostat peut avoir un impact significatif pour les patients br\u00e9siliens atteints de DMD \u00bb, a d\u00e9clar\u00e9 Antonio Nardi, vice-pr\u00e9sident et responsable du d\u00e9veloppement commercial et du portefeuille d&#039;Italfarmaco. \u00ab Notre partenariat avec Multicare, leader dans le domaine des maladies rares et tr\u00e8s complexes, pr\u00e9sent au Br\u00e9sil, nous permet d&#039;apporter ce traitement innovant \u00e0 ceux qui en ont le plus besoin. \u00bb<\/p>","protected":false},"excerpt":{"rendered":"<p>Italfarmaco announced an exclusive agreement with Multicare Pharma, a prominent pharmaceutical company in Latin America. Multicare Pharma will support the regulatory approval in Brazil and distribute givinostat (Duvyzat), Italfarmaco\u2019s novel histone deacetylase (HDAC) inhibitor to treat Duchenne muscular dystrophy (DMD). According to the terms of the agreement, Multicare will manage supply and distribution operations for [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":4491,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[281],"tags":[82,46,47,311,420],"class_list":["post-4490","post","type-post","status-publish","format-standard","has-post-thumbnail","category-press-releases","tag-brazil","tag-duvyzat","tag-givinostat","tag-italfarmaco","tag-multicare-pharma"],"_links":{"self":[{"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/posts\/4490","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/comments?post=4490"}],"version-history":[{"count":0,"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/posts\/4490\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/media\/4491"}],"wp:attachment":[{"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/media?parent=4490"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/categories?post=4490"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/tags?post=4490"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}